Terpene Profile (Comparative Values)
- 18.55% (Pine/Sharp)
- 65.96% (Herbal/Musk)
- 3.09% (Floral/Spice)
- 2.72% (Woody/Earthy)
- 8.24% (Herbal/Sweet)
- 1.44% (Floral/Herbal)
MedBud currently tracks 16 common terpenes, more will be added.
- Bedica T14:C1
- THC Potential Range (10% Legal Variance)
- CBD Potential Range (10% Legal Variance)
- Cultivated in
- Packaged in
- Flower Provided
- Ground Bud
We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.
Best Known Status: Low (IPS)
Main Importer/Distributor (Authoritative Stock)
A proprietary strain from Bedrocan BV.
Little is known about this strain other than it being bred in-house by the cultivator. While patient rumours persist over the origins of this strain, none are currently confirmed.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
🇳🇱 About Bedrocan B.V.
Bedrocan is an EU-GMP certified supplier of pharmaceutical grade cannabis to the Dutch Office of Medicinal Cannabis (OMC). Our high quality products are used as pharmaceutical raw materials and active pharmaceutical ingredients (APIs). We operate two indoor cultivation facilities and an R&D facility in the Netherlands.
Bedrocan strives to develop and deliver the full medical potential of the cannabis plant to those in need worldwide.
We strongly believe herbal cannabis can, and should, meet all of the existing regulations for medicines. At Bedrocan we strive to achieve the registration of herbal cannabis as an official medicine through a regulatory process that is acceptable to patients, regulators, and healthcare professionals.
Bedrocan aims to bridge the gap between patients’ needs and the regulatory demands of modern medicine by using rigorous scientific methods and testing to achieve safety and efficacy. We do this:
- through an active research program and a commitment to sharing our knowledge through scientific publications,
- by offering pharmaceutical quality cannabis under nationally and federally regulated medicinal cannabis programmes worldwide.
Coming soon, this feature is currently under active development.